The contemporary modern residence, constructed by Boerne-based Garner Homes, includes a wine room, hidden doors and ...

Fitell Corporation (Nasdaq: FTEL) (“Fitell” or the “Company”), an online retailer of gym and fitness equipment in Australia, today announced that it has entered into a definitive agreement with an ...

Swepson is among three high-profile Brisbane players yet to be contracted to the Heat for next season, the other two being Test star Marnus Labuschagne and Renshaw. Labuschagne, who made only one ...

U.S. President Donald Trump is expected to announce new tariffs against Canada and Mexico that will begin on March 1, but will include a process for the countries to seek specific exemptions for ...

Four! Played towards mid wicket. Queensland vs New South Wales Live Score: Queensland Angus Lovell 2 (12) Matt Renshaw 5 (6) ...

D. Boral Capital reissued their buy rating on shares of Quince Therapeutics (NASDAQ:QNCX – Free Report) in a report issued on Wednesday,Benzinga reports. D. Boral Capital currently has a $12.00 price ...

Rodman & Renshaw initiated coverage of Indivior (INDV) with a Buy rating and $16 price target Invest with Confidence: Follow TipRanks' Top ...

Wedbush upgraded shares of Bicara Therapeutics (NASDAQ:BCAX – Free Report) to a strong-buy rating in a research note released on Wednesday,Zacks.com reports. Other equities research analysts have also ...

周一，Rodman & Renshaw的分析师Elemer Piros将GH Research PLC (NASDAQ: GHRS )的12个月目标价从此前的24.00美元上调至42.00美元。在该公司宣布其用于治疗难治性抑郁症 (TRD)的可吸入mebufotenin候选药物GH001的临床试验取得成功后，该机构维持对该股票的买入评级。

周二，Rodman & Renshaw对Cardiol Therapeutics (NASDAQ: CRDL )股票进行了首次评级，给予"买入"评级，目标价为7.00美元。该公司的这一举动反映了其对Cardiol Therapeutics在开发用于治疗更广泛心脏病的口服大麻素平台方面取得的进展充满信心。